Yoshida Keisuke, Yamaguchi Kazuya, Sone Takayuki, Unno Yuka, Asai Akira, Yokosawa Hideyoshi, Matsuda Akira, Arisawa Mitsuhiro, Shuto Satoshi
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
Org Lett. 2008 Aug 21;10(16):3571-4. doi: 10.1021/ol8013304. Epub 2008 Jul 19.
A series of chiral 2,3- and 3,4-methanoamino acid equivalents of stereochemical diversity were designed and synthesized from our chiral cyclopropane units, using a diastereoselective Grignard addition with ( R)- or ( S)- t-butanesulfinyl imines as the key step. These equivalents were converted into the proteasome inhibitor belactosin A and its cis-cyclopropane stereoisomer. The unnatural cis-isomer was shown to be more than twice as potent as belactosin A as a proteasome inhibitor.
我们以手性环丙烷单元为原料,通过以(R)-或(S)-叔丁基亚磺酰亚胺的非对映选择性格氏加成反应作为关键步骤,设计并合成了一系列具有立体化学多样性的手性2,3-和3,4-亚甲基氨基酸类似物。这些类似物被转化为蛋白酶体抑制剂贝拉克托辛A及其顺式环丙烷立体异构体。结果表明,这种非天然的顺式异构体作为蛋白酶体抑制剂的活性是贝拉克托辛A的两倍多。